Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | ALPG | P10696 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79298 | 1.00 | ERN1 (1.00) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL29114876 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL11417323 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL30661195 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL29924535 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| Potassium SCHEMBL30661193 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL29114875 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| SCHEMBL11417328 | 0.98 | ERN1 (0.96) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| Hydrazine SCHEMBL28550593 | 0.96 | ERN1 (0.93) | ERN1POLBALDH1A1SMN1; SMN2GPR35 | |
| Ethylene SCHEMBL28992810 | 0.96 | ERN1 (0.93) | ERN1POLBALDH1A1SMN1; SMN2GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181773-A1 | VISUALIZABLE RADIOACTIVE CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2023-06-15 | — | — | US | claimed |
| US-20230149570-A1 | METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2023-05-18 | — | — | US | claimed |
| US-12533430-B2 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2026-01-27 | — | — | US | disclosed |
| EP-3375771-B1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | UBE CORP (JP) | 2025-11-26 | — | — | EP | disclosed |
| CN-119680014-A | Anti-infection bone repair composite material targeting intracellular bacteria and preparation method thereof | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2025-03-25 | — | — | CN | disclosed |
| US-20250002496-A1 | INDOLE DERIVATIVES AS A MATRIX DESIGN FRAMEWORK FOR MALDI MASS SPECTROMETRY WITH BROAD APPLICATIONS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2025-01-02 | — | — | US | disclosed |
| US-20230181773-A1 | VISUALIZABLE RADIOACTIVE CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230149570-A1 | METAL NUCLIDE-LOADED CARBON MICROSPHERE (CMS), PREPARATION METHOD, AND USE THEREOF | Chengdu New Radiomedicine Technology Co., Ltd. (CN) | 2023-05-18 | — | — | US | disclosed |
| US-11623943-B2 | Method for producing lacosamide and intermediate thereof | API CORPORATION (JP) | 2023-04-11 | — | — | US | disclosed |
| WO-2022259267-A1 | A METHOD FOR OBTAINING L-GLUFOSINATE | UPL LIMITED (IN) | 2022-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533430-B2 | Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof | CPS1, SRM, NES | ERN1 4569/4885POLB 2118/4885ALDH1A1 1172/4885 |
| US-20250002496-A1 | INDOLE DERIVATIVES AS A MATRIX DESIGN FRAMEWORK FOR MALDI MASS SPECTROMETRY WITH BROAD APPLICATIONS | IDO1, IDO2, AANAT | ERN1 4726/4885POLB 2980/4885ALDH1A1 2733/4885 |
| US-11623943-B2 | Method for producing lacosamide and intermediate thereof | CA3, TREH, NAAA | ERN1 2007/4885POLB 2804/4885ALDH1A1 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.